Correction to “Involvement of nuclear factor kB, not pregnane X receptor, in inflammation-mediated regulation of hepatic transporters” (Drug Metabolism Disposition (2017) 45:10 (1077-1083) DOI: 10.1124/dmd.117.076927);Involvement of nuclear factor κB, not pregnane X receptor, in inflammation-mediated regulation of hepatic transporters

Drug Metabolism and Disposition

Volumn 45, Issue 10, 2017, Pages 1077-1083

  Abualsunun, Walaa A ^a   Piquette Miller, Micheline ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHA 408; PREGNANE X RECEPTOR; PROTEIN INHIBITOR; SOLUTE CARRIER PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AUTACOID; CARRIER PROTEIN; STEROID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL NUCLEUS; KNOCKOUT MOUSE; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL NUCLEUS; DOWN-REGULATION; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85029532523     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.117.076927err     Document Type: Erratum

References (36)

1. Abualsunun WA. and Piquette-Miller M (2017) Regulation of Hepatic Transporters in Mice During Acute Inflammation; Involvement of NF-KB and Pregnane X Receptor. Clin. Pharmacol. Therap. 101(S1):S–98.
2. Aitken AE, Richardson TA, and Morgan ET (2006) Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 46:123–149.
3. Anapolsky A, Teng S, Dixit S, and Piquette-Miller M (2006) The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and -metabolizing enzymes in mice. Drug Metab Dispos 34:405–409.
4. Ayrton A and Morgan P (2001) Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31:469–497.
5. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, and Feingold KR (2000) The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275: 16390–16399.
6. Carlson CG, Dole E, Stefanski C, and Bayless D (2015) The effect of specific IKKb inhibitors on the cytosolic expression of IkB-a and the nuclear expression of p65 in dystrophic (MDX) muscle. Am J Transl Res 7:670–682.
7. Copeland S, Warren HS, Lowry SF, Calvano SE, and Remick D; Inflammation and the Host Response to Injury Investigators (2005) Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12:60–67.
8. Durk MR, Han K, Chow EC, Ahrens R, Henderson JT, Fraser PE, and Pang KS (2014) 1a,25-Dihydroxyvitamin D3 reduces cerebral amyloid-b accumulation and improves cognition in mouse models of Alzheimer’s disease. J Neurosci 34:7091–7101.
9. Fan X, Chai L, Zhang H, Wang Y, Zhang B, and Gao X (2015) Borneol depresses P-glycoprotein function by a NF-kB signaling mediated mechanism in a blood brain barrier in vitro model. Int J Mol Sci 16:27576–27588.
10. Goralski KB, Hartmann G, Piquette-Miller M, and Renton KW (2003) Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139:35–48.
11. Hartmann G, Vassileva V, and Piquette-Miller M (2005) Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. Drug Metab Dispos 33:820–828.
12. Hoesel B and Schmid JA (2013) The complexity of NF-kB signaling in inflammation and cancer. Mol Cancer 12:86.
13. Kalaany NY and Mangelsdorf DJ (2006) LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol 68:159–191.
14. Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1:a001651.
15. Mbalaviele G, Sommers CD, Bonar SL, Mathialagan S, Schindler JF, Guzova JA, Shaffer AF, Melton MA, Christine LJ, Tripp CS, et al. (2009) A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models. J Pharmacol Exp Ther 329:14–25.
16. Mencarelli A, Renga B, Palladino G, Claudio D, Ricci P, Distrutti E, Barbanti M, Baldelli F, and Fiorucci S (2011) Inhibition of NF-kB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. Eur J Pharmacol 668:317–324.
17. Morgan ET (1997) Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 29:1129–1188.
18. Morgan ET (2001) Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab Dispos 29:207–212.
19. Morgan ET (2009) Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther 85:434–438.
20. Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, Liddle C, et al. (2008) Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36:205–216.
21. Morgan ET, Li-Masters T, and Cheng PY (2002) Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology 181–182:207–210.
22. Oeckinghaus A and Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1:a000034.
23. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853–6866.
24. Pan W, Yu C, Hsuchou H, and Kastin AJ (2010) The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors. Cell Physiol Biochem 25:623–630.
25. Petrovic V, Teng S, and Piquette-Miller M (2007) Regulation of drug transporters during infection and inflammation. Mol Interv 7:99–111.
26. Rajendrasozhan S, Hwang JW, Yao H, Kishore N, and Rahman I (2010) Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke. Pulm Pharmacol Ther 23:172–181.
27. Ros JE, Schuetz JD, Geuken M, Streetz K, Moshage H, Kuipers F, Manns MP, Jansen PL, Trautwein C, and Müller M (2001) Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling. Hepatology 33: 1425–1431.
28. Tak PP and Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7–11.
29. Teng S and Piquette-Miller M (2005) The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312:841–848.
30. Teng S and Piquette-Miller M (2008) Regulation of transporters by nuclear hormone receptors: implications during inflammation. Mol Pharm 5:67–76.
31. Tirona RG and Kim RB (2005) Nuclear receptors and drug disposition gene regulation. J Pharm Sci 94:1169–1186.
32. Urquhart BL, Tirona RG, and Kim RB (2007) Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 47:566–578.
33. Wahli W (2008) A gut feeling of the PXR, PPAR and NF-kappaB connection. J Intern Med 263: 613–619.
34. Xie W and Tian Y (2006) Xenobiotic receptor meets NF-kappaB, a collision in the small bowel. Cell Metab 4:177–178.
35. Zhou C, Tabb MM, Nelson EL, Grün F, Verma S, Sadatrafiei A, Lin M, Mallick S, Forman BM, Thummel KE, et al. (2006) Mutual repression between steroid and xenobiotic receptor and NF-kB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 116: 2280–2289.
36. Zordoky BN and El-Kadi AO (2009) Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab 10:164–178.